TRANSMEDICS GROUP INC (TMDX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for TMDX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| TMDX | Director; Chairperson of the Audit Committee | ["audit committee financial expert","sufficient knowledge in financial and auditing matters"] | ["Audit Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| OCUL | Director | 70 | [] | [] | 2026 |
| WTS | Director; Chairperson | 70 | ["Chief Financial Officer of IDEXX Laboratories, Inc. from October 2003 to May 2013", "Executive Vice President of IDEXX from July 2012 to May 2013", "Corporate Vice President of Finance", "Vice President of Finance and Treasurer", "Director of Finance", "Controller", "Board member of Aratana Therapeutics, Inc. from February 2014 to July 2019", "Board member of Benchmark Electronics, Inc. from May 2018 to June 2021", "Board member of TransMedics Group, Inc. since January 2021", "Board member of Ocular Therapeutix, Inc. since September 2021", "audit committee financial expert", "Operational Experience developing and implementing operating plans and business strategy", "Finance/Capital Allocation", "Mergers & Acquisitions", "Supply Chain/Logistics", "Digital/eCommerce", "Marketing/Sales & Brand Management"] | ["Audit Committee", "Governance and Sustainability Committee"] | 2026 |
| BHE | Director | 65 | ["Retired Chief Financial Officer of IDEXX Laboratories, Inc."] | [] | 2021 |
| IDXX | Former Executive Vice President and Chief Financial Officer | [] | [] | 2014 |
Biography sourced from the proxy statement filing.
Merilee Raines, age 70, has served as a member of our Board since January 2021. Ms. Raines served as Chief Financial Officer of IDEXX Laboratories, Inc. from October 2003 until her retirement in May 2013. Prior to becoming Chief Financial Officer, Ms. Raines held several management positions with IDEXX Laboratories, including Corporate Vice President of Finance, Vice President and Treasurer of Finance, Director of Finance, and Controller. IDEXX Laboratories develops, manufactures, and distributes diagnostic and information technology-based products and services primarily for companion animals, livestock, poultry, water quality and food safety, and human point of care diagnostics. Ms. Raines has served on the board of directors of Watts Water Technologies, Inc. since 2011, and serves on its audit committee and nominating and corporate governance committee. Ms. Raines has served on the board of directors of Ocular Therapeutics, Inc. since September 2021 and serves on its audit committee. Ms. Raines previously served on the board of directors of Benchmark Electronics, Inc., from 2018 until 2021. Ms. Raines has also served on the boards of directors of several private companies, including Excelitas Technologies Corporation since 2018 and previously Dead River Company from 2018 until 2021. Ms. Raines received a Bachelor s Degree in mathematics from Bowdoin College and an MBA from the University of Chicago. We believe that Ms. Raines is qualified to serve on our Board because of her extensive financial expertise and experience as an executive and director of public companies.